首页> 外文期刊>Natural product sciences >Anti-hyperglycemic and Anti-hyperlipidemic Effects of the Triterpenoid-Rich Fractions from Rubus coreanus and Rubus crataegifolius and Their Main Component, Niga-ichigoside F_1, in Streptozotocin-induced Diabetic Rats
【24h】

Anti-hyperglycemic and Anti-hyperlipidemic Effects of the Triterpenoid-Rich Fractions from Rubus coreanus and Rubus crataegifolius and Their Main Component, Niga-ichigoside F_1, in Streptozotocin-induced Diabetic Rats

机译:链脲佐菌和山茱Rub及其主要成分Nig-ichigoside F_1的富含三萜类成分的抗降血糖和降血脂作用在链脲佐菌素诱导的糖尿病大鼠中

获取原文
获取原文并翻译 | 示例
           

摘要

To find the antidiabetic activity of the tripterpenoid-rich fractions of Rubus coreanus (TRF-cor) and R. crataegifolius (TRF-cra) leaves or its main component niga-ichigoside F_1 (Niga-F_1), anti-hyperglycemic and anti-hyperlipidemic effects were investigated in the diabetic rat model induced by streptozotocin (STZ). Treatments of rats with 200 mg/kg of the TRF-cor, TRF-cra (each, p.o.) or 20 mg/kg of Niga-Fi significantly inhibited the increase of blood glucose concentration about 44.8%, 28.7% or 20.6%, respectively, in the diabetic rats. In addition, treatments with those fractions inhibited the increase of serum concentrations of triglyceride, total cholesterol or LDL-cholesterol caused by STZ. The inhibitory rate on atherogenic index (AI) values of the TRF-cor (200 mg/kg), TRF-cra (200 mg/kg) or Niga-Fi (20 mg/kg)-treated groups were decreased about 55.7%, 36.3% or 22.6%, respectively, comparable to STZ-treated group. In the oral glucose tolerance test, treatment of TRF-cor or TRF-cra inhibited the increase of blood glucose concentration in the STZ-induced rats. Administration of 20 mg/kg of Niga-F_1 (p.o.) also exhibited similar effects with the effects of both TRFs at 200 mg/kg dose (p.o.). These results support that the triterpenoids, in particular Niga-F_1, are contributed to the antidiabetic effects of R. coreanus or R. crataegifolius.
机译:要找到富含三萜类成分的悬钩子(TRF-cor)和山楂红景天(TRF-cra)叶片或其主要成分ni-ichigoside F_1(Niga-F_1)的抗糖尿病活性,具有降血糖和降血脂作用在链脲佐菌素(STZ)诱导的糖尿病大鼠模型中研究了这种作用。用200 mg / kg的TRF-cor,TRF-cra(每个,口服)或20 mg / kg的Niga-Fi处理的大鼠分别显着抑制了血糖浓度的升高,分别约为44.8%,28.7%或20.6%。 ,在糖尿病大鼠中。另外,用这些级分进行的治疗抑制了由STZ引起的血清甘油三酯,总胆固醇或LDL-胆固醇浓度的升高。 TRF-cor(200 mg / kg),TRF-cra(200 mg / kg)或Niga-Fi(20 mg / kg)处理组的动脉粥样硬化指数(AI)值抑制率降低了约55.7%,与STZ治疗组相当,分别为36.3%或22.6%。在口服葡萄糖耐量试验中,TRF-cor或TRF-cra的治疗抑制了STZ诱导的大鼠血糖浓度的增加。施用20 mg / kg的Niga-F_1(p.o.)也表现出相似的效果,而两种TRF的剂量均为200 mg / kg(p.o.)。这些结果支持三萜类化合物,特别是Niga-F_1,有助于R. coreanus或R. crataegifolius的抗糖尿病作用。

著录项

相似文献

  • 外文文献
  • 中文文献
  • 专利
获取原文

客服邮箱:kefu@zhangqiaokeyan.com

京公网安备:11010802029741号 ICP备案号:京ICP备15016152号-6 六维联合信息科技 (北京) 有限公司©版权所有
  • 客服微信

  • 服务号